Traditional Chinese medicine and lung cancer-From theory to practice

被引：214
作者：
Li, Zhang [1 ,2 ]
Feiyue, Zhang [1 ,2 ]
Gaofeng, Li [2 ]
机构：
[1] Kunming Med Univ, Kunming 650500, Yunnan, Peoples R China
[2] Yunnan Canc Ctr, Dept Thorac Tumor Surg, Kunming 650118, Yunnan, Peoples R China
来源：
BIOMEDICINE & PHARMACOTHERAPY | 2021年 / 137卷
基金：
中国国家自然科学基金;
关键词：
Lung cancer; Traditional Chinese medicine; Adjuvant therapy; Immunotherapy; QUALITY-OF-LIFE; EPITHELIAL-MESENCHYMAL TRANSITION; CELL-CYCLE ARREST; DOUBLE-BLIND; IN-VITRO; APOPTOSIS; CHEMOTHERAPY; THERAPY; ACUPUNCTURE; METASTASIS;
D O I：
10.1016/j.biopha.2021.111381
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
With the continuous breakthroughs in molecular biology and biochemistry, we have constantly made great progress in the treatment of lung cancer. There is no doubt that standard treatment (such as surgery, radiotherapy, chemotherapy, targeted therapy, and immunotherapy) has greatly improved the prognosis of lung cancer populations. In particular, the immunotherapy has brought more and more good news to countless lung cancer patients. In contrast to these standard treatments, traditional Chinese medicine (TCM) rarely has a profound and comprehensive overview in the field of lung cancer. This article will summarize the latest progress of TCM in lung cancer which is mainly non-small cell lung cancer (NSCLC) from theory to clinical practice, which would carry forward the sophisticated TCM and promote the development of modern medicine.
引用
收藏
页数：5
相关论文
共 75 条
[1]   Development of a vaccine based on bacteria-mimicking tumor cells coated with novel engineered toll-like receptor 2 ligands [J].
Akazawa, Takashi ;
Ohashi, Toshimitsu ;
Wijewardana, Viskam ;
Sugiura, Kikuya ;
Inoue, Norimitsu .
CANCER SCIENCE, 2018, 109 (05) :1319-1329
[2]   Acupuncture for Dyspnea in Lung Cancer: Results of a Feasibility Trial [J].
Bauml, Joshua ;
Haas, Andrew ;
Simone, Charles B., II ;
Li, Susan Q. ;
Cohen, Roger B. ;
Langer, Corey J. ;
Mao, Jun J. .
INTEGRATIVE CANCER THERAPIES, 2016, 15 (03) :326-332
[3]   Complementary Therapies and Integrative Medicine in Lung Cancer Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [J].
Deng, Gary E. ;
Rausch, Sarah M. ;
Jones, Lee W. ;
Gulati, Amitabh ;
Kumar, Nagi B. ;
Greenlee, Heather ;
Pietanza, M. Catherine ;
Cassileth, Barrie R. .
CHEST, 2013, 143 (05) :E420-E436
[4]   Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study [J].
Deng, Lisi ;
Li, Chunna ;
Zeng, Qi ;
Liu, Xi ;
Li, Xinghua ;
Zhang, Haitang ;
Hong, Zhongsi ;
Xia, Jinyu .
JOURNAL OF INFECTION, 2020, 81 (01) :E1-E5
[5]  
Fu HY, 2018, AM J CHINESE MED, V46, P911, DOI [10.1142/S0192415X18500489, 10.1142/s0192415x18500489]
[6]  
Gardani G, 2006, Minerva Med, V97, P391
[7]   A High-Throughput Assay for Screening of Natural Products that Enhanced Tumoricidal Activity of NK Cells [J].
Gong, Chenyuan ;
Ni, Zhongya ;
Yao, Chao ;
Zhu, Xiaowen ;
Ni, Lulu ;
Wang, Lixin ;
Zhu, Shiguo .
BIOLOGICAL PROCEDURES ONLINE, 2015, 17
[8]   Cancer statistics, 2007 [J].
Jemal, Ahmedin ;
Siegel, Rebecca ;
Ward, Elizabeth ;
Murray, Taylor ;
Xu, Jiaquan ;
Thun, Michael J. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2007, 57 (01) :43-66
[9]   The antitumour effects of eudesmin on lung cancer by inducing apoptosis via mitochondria-mediated pathway in the tumour cells [J].
Jiang, Li-Li ;
Sun, Bai-Rong ;
Zheng, Chao ;
Yang, Gui-Lun .
PHARMACEUTICAL BIOLOGY, 2017, 55 (01) :2259-2263
[10]  
Jiang Y, 2016, Zhonghua Zhong Liu Za Zhi, V38, P757, DOI 10.3760/cma.j.issn.0253-3766.2016.10.009
12345678